ACMT Position Statement: Position on the Recent Judicial Challenge of U.S. Food and Drug Administration Approval of Mifepristone.

Mazer-Amirshahi, Maryann; Stolbach, Andrew I; Ye, Peggy

Mazer-Amirshahi, Maryann; Stolbach, Andrew I; Ye, Peggy.

Afiliación

Mazer-Amirshahi M; Georgetown University School of Medicine, Washington, DC, USA.
Stolbach AI; Department of Emergency Medicine, MedStar Washington Hospital Center, Washington, DC, USA.
Ye P; Johns Hopkins University School of Medicine, Baltimore, MD, USA. positionstatements@acmt.net.

J Med Toxicol ; 19(4): 414-415, 2023 10.

Article en En | MEDLINE | ID: mdl-37548894

Asunto(s)

Mifepristona; Estados Unidos; Humanos; Mifepristona/efectos adversos; United States Food and Drug Administration

Palabras clave

Drug safety; FDA; Mifepristone; Pregnancy; Toxicology

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Mifepristona País/Región como asunto: America do norte Idioma: En Revista: J Med Toxicol Asunto de la revista: TOXICOLOGIA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google